Wei-Le Wang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Circular RNAs in diseases 3
- Biochemical and Structural Characterization 1
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Co-authors
- Mark Boldin (6 shared papers)Steven Vonderfecht (2 shared papers)Nelson Chau (2 shared papers)Nicholas J. Kramer (2 shared papers)Edouard M. Cantin (1 shared paper)Ching‐Cheng Chen (2 shared papers)Bijender Kumar (2 shared papers)Chandran Ramakrishna (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)The Journal of Immunology (2 papers)PLoS Biology (1 paper)Nature Communications (1 paper)Immunity (1 paper)
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Wei-Le Wang
10 papers receiving 236 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 99
- Neurology 43
- Immunology 84
- Biological Psychiatry 8
- Molecular Biology 135
Countries citing papers authored by Wei-Le Wang
This map shows the geographic impact of Wei-Le Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Le Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Le Wang more than expected).
Fields of papers citing papers by Wei-Le Wang
This network shows the impact of papers produced by Wei-Le Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Le Wang. The network helps show where Wei-Le Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-Le Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 90 | |
| 2 | 2017 | 43 | |
| 3 | 2023 | 42 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 13 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 4 | |
| 9 | 2015 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 0 |
About Wei-Le Wang
Wei-Le Wang is a scholar working on Molecular Biology, Cancer Research, Immunology, Surgery and Nephrology, having authored 11 papers that have together received 237 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (3 papers), IL-33, ST2, and ILC Pathways (2 papers), Immune Cell Function and Interaction (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Biochemical and Structural Characterization (1 paper) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Cancer Research (99 citations), Neurology (43 citations), Immunology (84 citations), Biological Psychiatry (8 citations) and Molecular Biology (135 citations). Wei-Le Wang has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Mark Boldin, Steven Vonderfecht, Nelson Chau, Nicholas J. Kramer, Edouard M. Cantin, Ching‐Cheng Chen, Bijender Kumar, Chandran Ramakrishna, Konstantin D. Taganov and Jin Gohda. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology, PLoS Biology, Nature Communications and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.